Bente Langdahl

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos et al. · The Lancet Diabetes & Endocrinology · 2019 · 169 citations

Pharmacy, Pharmacotherapy, Bone Metabolism +10

Treatment of postmenopausal osteoporosis with bone-forming and antiresorptive treatments: Combined and sequential approaches

Bente Langdahl · Bone · 2020 · 89 citations

Medicine, Endocrinology, Orthopedic Surgery +16

Effects of Teriparatide in Patients with Osteoporosis in Clinical Practice: 42-Month Results During and After Discontinuation of Treatment from the European Extended Forsteo® Observational Study (ExFOS)

Nicola Napoli, Bente Langdahl, Östen Ljunggren et al. · Calcified Tissue International · 2018 · 40 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid study

Francis H. Glorieux, Bente Langdahl, Roland Chapurlat et al. · Journal of Bone and Mineral Research · 2024 · 28 citations · Full text

Medicine, Orthopaedic Surgery, Pharmacotherapy +17

Pycnodysostosis in children and adults

Jannie Dahl Hald, Signe Sparre Beck‐Nielsen, Pernille Axél Gregersen et al. · Bone · 2023 · 23 citations

Medicine, Pediatrics, Pediatric Pathology +1